FIGURE 14
FROM:
Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies
D Evenden, P R Harper, S C Brailsford and V Harindra
BACK TO ARTICLEFigure 14.

Cost savings for infection prevalence at 10%.
FROM:
D Evenden, P R Harper, S C Brailsford and V Harindra
BACK TO ARTICLE
Cost savings for infection prevalence at 10%.